Digital Health

Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.   

The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.

Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.

The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.

Nomi Health appointed its first chief product officer, and Hims & Hers announced that its first chief medical officer has returned to the role.

Aegis Ventures' John Beadle discusses partnerships between venture capital firms and health systems, the move from direct-to-consumer to business-to-business models and what digital health investment could look like next year.

The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.

MediOrbis will incorporate Kahun's AI tool into its platform to provide clinical insights to healthcare providers based on patients’ intake information.   

The investment will support Nectar's growth nationwide, fund clinical trials and help the company open a physical location.

The startup offers access to advocates who can help family caregivers make plans or solve problems as well as a digital health platform.